Shukra Pharmaceuticals Ltd
₹0.00▲ +0.00 (+0.00%)
SHUKRAPHARMACEUTICALSLTD·NSE·Healthcare
Market Cap
1705.75 Cr
PE Ratio
72.80
Volume
—
Day High - Low
—
52W High-Low
65.26 - 17.06
₹0.00▲ +0.00 (+0.00%)
Market Cap1705.75 Cr
PE Ratio72.80
Volume—
Day High - Low—
52W High-Low65.26 - 17.06
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
28.90%
Strong
P/E
72.80x
Expensive
Debt / Equity
0.06
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹17.06
₹65.26
DocStoX take
Supported by growth (10.0) and quality (7.5), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence5.7
/10
Fair
Quality
Excellent
ROE 28.9%
Valuation
Expensive
P/E 72.8×
Growth
Strong
Revenue +38.8% 5Y CAGR
Risk
Elevated
D/E 0.06
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹1,706 Cr
52W High / Low
₹65 / ₹17
Dividend Yield
0.03%
Promoter Holding
51.15%
EPS (TTM)
₹0.22
Book Value
₹2.18
Key highlights
- Profit compounding 71% a year
- Revenue compounding 39% a year
- Healthy net margin (30%)
- Valuation is weak (0.0/10)
- Expensive at 73× earnings
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Shukra Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Shukra Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDMANKIND PHARMA LIMITEDLAURUS LABS LIMITEDLUPIN LIMITEDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMAX HEALTHCARE INS LTD
Compare Shukra Pharmaceuticals Ltd with peers
Shukra Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND LShukra Pharmaceuticals Ltd vs DIVI S LABORATORIES LTDShukra Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS LShukra Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. LShukra Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTDShukra Pharmaceuticals Ltd vs CIPLA LTD
Related tools & concepts
Value Shukra Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing